Skip to content

Programming by Estrogen Treatment in Gonadotropin Releasing Hormone Antagonist Protocol

Programming by Estrogen Treatment in Gonadotropin Releasing Hormone Antagonist Protocol

Status
Completed
Phases
Phase 4
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT01419353
Enrollment
63
Registered
2011-08-18
Start date
2011-08-31
Completion date
2013-06-30
Last updated
2013-12-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Infertility

Keywords

Infertility, IVF, Estrogen

Brief summary

The purpose of this study is to determine if pretreatment with Estrogen can assist in the planning and programming of In Vitro Fertilization treatments.

Detailed description

A randomised controlled trial in which study group will be given estrogen derivative before ovarian stimulation in GnRH antagonist protocol and compared to the classical GnRH agonist protocol.Estrogen will be given P.O , PROGYNOVA' , in a dose of 2 mg /d, starting day 2 of menses and until first Monday to follow. Main outcome measure will be ability to control the ovum pickup day, calculated as a rate of ideal pickups divided by the entire pickup number. All women enrolled will be under 38 years of age, with a clear indication for IVF other than ovulatory dysfunction. women with past 4 treatment failures will be excluded as well as cases in which sperm achieved in surgical methods.

Interventions

DRUGestradiol valerate

2 mg P.O / day for 1-6 days.

Sponsors

Meir Medical Center
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
NONE

Eligibility

Sex/Gender
FEMALE
Age
No minimum to 38 Years
Healthy volunteers
Yes

Inclusion criteria

* IVF treatment in the following indications: Male, Mechanical, Unexplained * Age\<38 years * Treatment Cycle number 1-4

Exclusion criteria

* Ovulatory disorder as an indication for IVF * Repeated failure in previous IVF treatments (\> than 4 cycles) * Sperm used for treatment was retrieved by surgical procedure

Design outcomes

Primary

MeasureTime frameDescription
ovum pickup rate that took place between Sunday to Thursday without a compromisea yearnumber of Pickups that took place between Sunday to Thursday (without a compromise in treatment) \\ by the entire pickup number

Secondary

MeasureTime frameDescription
pregnancy ratea yearcomparison of pregnancy rate between the 2 groups. calculated per cycle

Countries

Israel

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026